Selective Effects of a 4-oxystilbene Derivative on Wild and Mutant Neuronal Chick Alpha7 Nicotinic Receptor
Overview
Affiliations
1. We assessed the pharmacological activity of triethyl-(beta-4-stilbenoxy-ethyl) ammonium (MG624), a drug that is active on neuronal nicotinic receptors (nicotinic AChR). Experiments on the major nicotinic AChR subtypes present in chick brain, showed that it inhibits the binding of [125I]-alphaBungarotoxin (alphaBgtx) to the alpha7 subtype, and that of [3H]-epibatidine (Epi) to the alpha4beta2 subtype, with Ki values of respectively 106 nM and 84 microM. 2. MG624 also inhibited ACh elicited currents (I(ACh)) in the oocyte-expressed alpha7 and alpha4beta2 chick subtypes with half-inhibitory concentrations (IC50) of respectively 109 nM and 3.2 microM. 3. When tested on muscle-type AChR, it inhibited [125I]-alphaBgtx binding with a Ki of 32 microM and ACh elicited currents (I(ACh)) in the oocyte-expressed alpha1beta1gammadelta chick subtype with an IC50 of 2.9 microM. 4. The interaction of MG624 with the alpha7 subtype was investigated using an alpha7 homomeric mutant receptor with a threonine-for-leucine 247 substitution (L247T alpha7). MG624 did not induce any current in oocytes expressing the wild type alpha7 receptor, but did induce large currents in the oocyte-expressed L247T alpha7 receptor. The MG624 elicited current (I(MG62)) has an EC50 of 0.2 nM and a Hill coefficient nH of 1.9, and is blocked by the nicotinic receptor antagonist methyllycaconitine (MLA). 5. These binding and electrophysiological studies show that MG624 is a potent antagonist of neuronal chick alpha7 nicotinic AChR, and becomes a competitive agonist following the mutation of the highly conserved leucine residue 247 located in the M2 channel domain.
Arunrungvichian K, Vajragupta O, Hayakawa Y, Pongrakhananon V ACS Pharmacol Transl Sci. 2024; 7(1):28-41.
PMID: 38230275 PMC: 10789132. DOI: 10.1021/acsptsci.3c00138.
Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G Eur J Nucl Med Mol Imaging. 2011; 38(8):1541-9.
PMID: 21484373 DOI: 10.1007/s00259-011-1808-y.
Briggs C, Gronlien J, Curzon P, Timmermann D, Ween H, Thorin-Hagene K Br J Pharmacol. 2009; 158(6):1486-94.
PMID: 19845675 PMC: 2795215. DOI: 10.1111/j.1476-5381.2009.00426.x.
Cholinergic regulation of epithelial ion transport in the mammalian intestine.
Hirota C, McKay D Br J Pharmacol. 2006; 149(5):463-79.
PMID: 16981004 PMC: 2014671. DOI: 10.1038/sj.bjp.0706889.
Organ M, Mayer S, Lepifre F, NZemba B, Khatri J Mol Divers. 2004; 7(2-4):211-27.
PMID: 14870853 DOI: 10.1023/b:modi.0000006826.91512.83.